Cargando…
Modeling to capture bystander-killing effect by released payload in target positive tumor cells
BACKGROUND: Antibody-drug conjugates (ADCs) are intended to bind to specific positive target antigens and eradicate only tumor cells from an intracellular released payload through the lysosomal protease. Payloads, such as MMAE, have the capacity to kill adjacent antigen-negative (Ag–) tumor cells, w...
Autores principales: | Byun, Jong Hyuk, Jung, Il Hyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399851/ https://www.ncbi.nlm.nih.gov/pubmed/30832603 http://dx.doi.org/10.1186/s12885-019-5336-7 |
Ejemplares similares
-
Rational Design of Azastatin as a Potential ADC Payload with Reduced Bystander Killing
por: Hartmann, Rafael W., et al.
Publicado: (2020) -
Quantifying ADC bystander payload penetration with cellular resolution using pharmacodynamic mapping
por: Khera, Eshita, et al.
Publicado: (2020) -
A click chemistry-based, free radical-initiated delivery system for the capture and release of payloads
por: DiMartini, Emily T., et al.
Publicado: (2023) -
Quantification of intracellular payload release from polymersome nanoparticles
por: Scarpa, Edoardo, et al.
Publicado: (2016) -
Tumor-homing peptides as tools for targeted delivery of payloads to the placenta
por: King, Anna, et al.
Publicado: (2016)